Santhera Pharmaceuticals (SPHDF) Q3 2025 Earnings

23SepConfirmed
Q2 2024
Q3 2024
Q2 2025
Q3 2025
-3.83
-3.05
-2.28
-1.5

Details

Expected EPS
N/A
Actual EPS
-3.831616
Surprise EPS
-3.83
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (SPHDF) has reported earnings of -3.831616 per share for Q3 2025.

0 Comments

Share your thoughts